Plandaí Biotechnology, Inc.
PLPL
Rank in Stocks
#34192
Plandaí Biotechnology, Inc. specializes in developing distinctive botanical... Plandaí Biotechnology, Inc. specializes in developing distinctive botanical extracts intended for the nutriceutical and pharmaceutical industries. A primary focus is the development of its Phytofare Catechin Complex, an extract originating from green tea cultivated at the Senteeko Tea Estate in Mpumalanga, South Africa. The company is also advancing its Phytofare citrus complex, a citrus-based extract, alongside extracts derived from tomato fruit, Artemisia, and cannabis. Beyond its biotechnological pursuits, Plandaí operates agricultural holdings in South Africa, where it produces and sells timber and various other farm products. The company's corporate base is in London, United Kingdom.
Share Price
$0.000001
Last synced: 2026-11-10
Market Cap
$44.89K
Change (1 day)
0.00%
Change (1 year)
-99.00%
Country
Stock data: Financial Modeling Prep·Updated ·Not investment advice·How we calculate this
Trade Plandaí Biotechnology, Inc. (PLPL)
Category
Financial Services
Operating Margin for Plandaí Biotechnology, Inc. (PLPL)
Operating Margin as of November 2026 TTM: 0.00%
According to Plandaí Biotechnology, Inc.'s latest financial reports, its current operating margin (TTM) is 0.00%. At the end of 2025 the company had an operating margin of 0.00%.
Operating Margin history for Plandaí Biotechnology, Inc. from 2003 to 2026
Operating Margin at the end of each year
| Year | Operating Margin | Change |
|---|---|---|
| 2026 (TTM) | 0.00% | 0.00% |
| 2025 | 0.00% | 0.00% |
| 2024 | 0.00% | 0.00% |
| 2023 | 0.00% | 0.00% |
| 2022 | 0.00% | 0.00% |
| 2021 | 0.00% | 0.00% |
| 2020 | 0.00% | -100.00% |
| 2017 | -746.86% | -28.29% |
| 2016 | -1,041.56% | -89.07% |
| 2015 | -9,526.58% | 433.66% |
| 2014 | -1,785.15% | 141.20% |
| 2013 | -740.10% | -85.54% |
| 2012 | -5,117.39% | 75,489.22% |
| 2011 | -6.77% | -16.11% |
| 2010 | -8.07% | -28.46% |
| 2009 | -11.28% | 239.76% |
| 2008 | -3.32% | -51.46% |
| 2007 | -6.84% | 62.47% |
| 2006 | -4.21% | -70.14% |
| 2005 | -14.10% | 14.91% |
| 2004 | -12.27% | -18.90% |
| 2003 | -15.13% | 0.00% |
Operating Margin for similar companies or competitors
| Company | Operating Margin | Operating Margin Difference | Country |
|---|---|---|---|
| 0.00% | - |
US
|
|
| 9.21% | - |
US
|
|
| -2,061.14% | - |
CN
|
|
| 2.14% | - |
US
|
|
| -20,955.80% | - |
US
|
What is a company's Operating Margin?
The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.
Questions about Plandaí Biotechnology, Inc.'s operating margin
What was Plandaí Biotechnology, Inc.'s operating margin in 2025?
In 2025, Plandaí Biotechnology, Inc.'s operating margin was 0.00%, compared with 0.00% in 2024.
How has Plandaí Biotechnology, Inc.'s operating margin changed since 2020?
From 2020 to 2025, Plandaí Biotechnology, Inc.'s operating margin was highest in 2025 (0.00%) and lowest in 2025 (0.00%).
How does Plandaí Biotechnology, Inc.'s operating margin compare with similar companies?
Plandaí Biotechnology, Inc.'s operating margin (0.00%) is higher than that of 2 of the 5 similar companies listed above. The highest among them is Worldwide Webb Acquisition Corp., with 9.21%.